# US 2006/0156430 A1 · Novel cytochrome P450 monooxygenase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0156430 A1
- Document ID: US20060156430A1
- Status: Published application
- Kind: A1
- Application number: 11/329,255
- Filed: 2006-01-10
- Published: 2006-07-13
- Earliest claimed: 2005-01-13
- Inventors: Brian McGonigle; Saverio Falco; John Everard; Nicole Swinson
- Web page: https://patentgrep.com/patent/US20060156430A1

## CPC

- C12N 9/0077: {with a reduced iron-sulfur protein as one donor (1.14.15)}
- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- C12N 15/8247: {involving modified lipid metabolism, e.g. seed oil composition}
- C12P 7/04: acyclic
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

This invention relates to an isolated polynucleotide encoding a cytochrome P450 monooxygenase that in the presence of linoleic acid results in production of 1-octen-3-ol. The invention also relates to the construction of a recombinant DNA construct comprising all or a portion of the polynucleotide encoding the cytochrome P450 monooxygenases of the invention, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels 1-octen-3-ol in a transformed host cell.

## Claims

### Claim 1

An isolated polynucleotide comprising:
(a) a nucleotide sequence encoding a cytochrome P450 polypeptide having an amino acid sequence of at least 80% sequence identity, based on the Clustal V method of alignment, when compared to an amino acid sequence of SEQ ID NO:3 , wherein expression of said polypeptide in an appropriate host cell transformed with said isolated polynucleotide, in the presence of linoleic acid, results in an increased level of 1-octen-3-ol in said transformed host cell when compared to an nontransformed host cell; or
(b) a complement of the nucleotide sequence, wherein the complement and the nucleotide sequence consist of the same number of nucleotides and are 100% complementary.

### Claim 2 (depends on 1)

A portion of the polynucleotide of claim 1 wherein said portion is capable of suppressing production of 1-octen-3-ol when introduced into cells that normally produce 1-octen-3-ol.

### Claim 3

A portion of SEQ ID NOS: 2, 8, or 21 wherein said portion is capable of suppressing production of 1-octen-3-ol when introduced into cells that normally produce 1-octen-3-ol.

### Claim 4 (depends on 1)

A polynucleotide of claim 1 wherein said nucleotide sequence further comprises a native cytochrome P450 promoter region, a native cytochrome P450 terminator region, and a native cytochrome P450 intron.

### Claim 5 (depends on 4)

The polynucleotide of claim 4 wherein the nucleotide sequence comprises the nucleotide sequence in SEQ ID NO:8.

### Claim 6 (depends on 4)

The polynucleotide of claim 4 wherein the native cytochrome P450 promoter region comprises the nucleotide sequence in SEQ ID NO:21.

### Claim 7 (depends on 1)

The isolated polynucleotide of claim 1, wherein said polypeptide has an amino acid sequence of at least 85% sequence identity, based on the Clustal V method of alignment, when compared to an amino acid sequence of SEQ ID NO:3.

### Claim 8 (depends on 1)

The isolated polynucleotide of claim 1, wherein said polypeptide has an amino acid sequence of at least 90% sequence identity, based on the Clustal V method of alignment, when compared to an amino acid sequence of SEQ ID NO:3.

### Claim 9 (depends on 1)

The isolated polynucleotide of claim 1, wherein said polypeptide has an amino acid sequence of at least 95% sequence identity, based on the Clustal V method of alignment, when compared to an amino acid sequence of SEQ ID NO:3.

### Claim 10 (depends on 1)

The isolated polynucleotide of claim 1, wherein said polypeptide has an amino acid sequence of SEQ ID NO:3.

### Claim 11 (depends on 1)

The isolated polynucleotide of claim 1, wherein said polypeptide has an amino acid sequence of SEQ ID NO:22.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

A recombinant DNA construct comprising the polynucleotide of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 operably linked to at least one regulatory sequence.

### Claim 13 (depends on 12)

A transgenic cell comprising the recombinant DNA construct of claim 12.

### Claim 14 (depends on 13)

The cell of claim 13 wherein expression of said recombinant DNA construct results in an altered level of 1-octen-3-ol.

### Claim 15 (depends on 13)

The cell of claim 13 wherein expression of said recombinant DNA construct results in an increase in 1-octen-3-ol.

### Claim 16 (depends on 13)

The cell of claim 13 wherein expression of said recombinant DNA construct results in a decrease in 1-octen-3-ol.

### Claim 17 (depends on 12)

A plant comprising the recombinant DNA construct of claim 12.

### Claim 18 (depends on 12)

A plant transformed with the recombinant DNA construct of claim 12 and having an altered level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 19 (depends on 12)

A plant transformed with the recombinant DNA construct of claim 12 and having an increased level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 20 (depends on 12)

A plant transformed with the recombinant DNA construct of claim 12 and having a decreased level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A soybean plant whose genome comprises a disruption of the polynucleotide of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 wherein said disruption results in said plant exhibiting reduced 1-octen-3-ol when compared to its wild type counterpart.

### Claim 22 (depends on 17, 18, 19)

The plant of claims 17, 18, 19, or 20, wherein said plant is a soybean plant.

### Claim 23 (depends on 12)

A seed comprising the recombinant DNA construct of claim 12.

### Claim 24 (depends on 23)

The seed of claim 23 wherein said seed is a soybean seed.

### Claim 25 (depends on 12)

A method for transforming a cell, comprising transforming a cell with the recombinant DNA construct of claim 12.

### Claim 26 (depends on 12)

A method for producing a plant comprising:
transforming a plant cell with the recombinant DNA construct of claim 12,
regenerating a plant from the transformed plant cell; and
growing the transformed plant under conditions suitable for the expression of the recombinant DNA construct, said grown transformed plant having an altered level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 27 (depends on 26)

The method of claim 26, wherein said plant is a soybean plant.

### Claim 28 (depends on 26)

The method of claim 26, wherein said grown transformed plant has an increased level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 29 (depends on 26)

The method of claim 26, wherein said grown transformed plant has a decreased level of 1-octen-3-ol when compared to a non-transformed plant.

### Claim 30 (depends on 12)

A method of producing 1-octen-3-ol comprising: transforming a host cell with the recombinant DNA construct of claim 12; and adding linoleic acid to said transformed host cell in an amount sufficient for said host cell to produce 1-octen-3-ol.

### Claim 31 (depends on 30)

The method of claim 30 wherein said host cell is selected from the group consisting of yeast and an insect cell.

### Claim 32 (depends on 22)

Soybean grain from the plant of claim 22.

### Claim 33 (depends on 32)

Soybean protein product prepared from the soybean grain of claim 32.

### Claim 34 (depends on 32)

Soybean oil prepared from the soybean grain of claim 32.

### Claim 35 (depends on 32)

Feed prepared from the soybean grain of claim 32.

### Claim 36 (depends on 32)

A food prepared from the soybean grain of claim 32.

### Claim 37 (depends on 33)

A food prepared with the soybean protein product of claim 33.
